Table 2.

Psychosomatic assessment in TTS patients within the acute phase of the disease

Psychosomatic assessment
B IPQ	39.3 ± 10.8 (19–61)
Consequences	5.8 ± 2.7 (1–10)
Timeline	5.4 ± 3.5 (1–10)
Personal control	5.5 ± 2.4 (2–9)
Treatment control	6.4 ± 2.7 (1–9)
Identity	4.7 ± 2.6 (1–10)
Concern	5.6 ± 2.9 (1–10)
Understanding	6.3 ± 2.9 (2–10)
Emotional response	5.3 ± 3.1 (1–10)
Support from surrounding	67.8% ± 30.6 (5–10%)
Impact of emotional stress	58.8% ± 31 (5–100%)
Level of illness threat
Moderate to high	48.1%
Low	7.4%
Educational level
Low	51.9%
High	14.8%
Resilience	69.0 ± 16.6 (23–89)
Resilience level
High	37.0%
Low to moderate	40.7%